C
C4 Therapeutics D
D
CCCC
4.54500
USD
0.35
(8.34%)
Market Closed
Volume
35,640
EPS
-2
Div Yield
-
P/E
-3
Market Cap
320,826,819
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: C4 Therapeutics
Sector: Healthcare
Industry: Biotechnology
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.